This enabled a unique evaluation of the iodine avidity in primary tumour tissue, resected lymph node metastases, and comparison of avidity to the expression of iodine-transport related proteins (NIS, TPO, TSHR and pendrin), as well as mutations in the TERT promoter and codon V600 of the BRAF gene. Here, SLC26A4 is linked to neoplasm.